Beijing Kawin Technology Share-Holding Past Earnings Performance
Past criteria checks 4/6
Beijing Kawin Technology Share-Holding has been growing earnings at an average annual rate of 13.3%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 13% per year. Beijing Kawin Technology Share-Holding's return on equity is 8.6%, and it has net margins of 9.5%.
Key information
13.3%
Earnings growth rate
7.1%
EPS growth rate
| Biotechs Industry Growth | 11.3% |
| Revenue growth rate | 13.0% |
| Return on equity | 8.6% |
| Net Margin | 9.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Impressive Earnings May Not Tell The Whole Story For Beijing Kawin Technology Share-Holding (SHSE:688687)
Oct 28
Why Investors Shouldn't Be Surprised By Beijing Kawin Technology Share-Holding Co., Ltd.'s (SHSE:688687) 36% Share Price Surge
Oct 01We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt
May 06Beijing Kawin Technology Share-Holding Co., Ltd. (SHSE:688687) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Mar 14Revenue & Expenses Breakdown
How Beijing Kawin Technology Share-Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,420 | 134 | 828 | 170 |
| 30 Jun 24 | 1,440 | 121 | 888 | 152 |
| 31 Mar 24 | 1,518 | 117 | 969 | 142 |
| 31 Dec 23 | 1,412 | 117 | 899 | 134 |
| 30 Sep 23 | 1,326 | 105 | 890 | 113 |
| 30 Jun 23 | 1,236 | 85 | 867 | 106 |
| 31 Mar 23 | 1,181 | 80 | 855 | 116 |
| 31 Dec 22 | 1,160 | 83 | 852 | 114 |
| 30 Sep 22 | 1,275 | 98 | 954 | 96 |
| 30 Jun 22 | 1,184 | 109 | 889 | 90 |
| 31 Mar 22 | 1,144 | 111 | 846 | 88 |
| 31 Dec 21 | 1,144 | 107 | 849 | 77 |
| 30 Sep 21 | 1,033 | 98 | 741 | 70 |
| 30 Jun 21 | 1,002 | 85 | 716 | 67 |
| 31 Mar 21 | 912 | 80 | 639 | 60 |
| 31 Dec 20 | 862 | 76 | 603 | 56 |
| 30 Sep 20 | 825 | 55 | 607 | 51 |
| 31 Dec 19 | 825 | 54 | 618 | 35 |
| 31 Dec 18 | 706 | 45 | 508 | 53 |
| 31 Dec 17 | 491 | 27 | 354 | 43 |
| 31 Dec 15 | 268 | 24 | 163 | 0 |
| 31 Dec 14 | 225 | 12 | 131 | 0 |
| 31 Dec 13 | 200 | 17 | 102 | 0 |
Quality Earnings: 688687 has a high level of non-cash earnings.
Growing Profit Margin: 688687's current net profit margins (9.5%) are higher than last year (7.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688687's earnings have grown by 13.3% per year over the past 5 years.
Accelerating Growth: 688687's earnings growth over the past year (27.6%) exceeds its 5-year average (13.3% per year).
Earnings vs Industry: 688687 earnings growth over the past year (27.6%) exceeded the Biotechs industry 0.08%.
Return on Equity
High ROE: 688687's Return on Equity (8.6%) is considered low.